- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
短期行情可能回暖，可适量买进股票，作短线反弹行情。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有300家主力机构披露2025-12-31报告期持股数据，持仓量总计11.62亿股，占流通A股58.78%
- 波段诊断：
-
技术面诊股
诊断结果：4.9技术面打败了24%的股票
技术面评分前10的股票
近期的平均成本为14.10元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为14.10元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"14.10","date":1778056193,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，接近行业平均水平。
[{"date":"2026.05.07","stock":"-0.35","trade":"0.68","ind":"0.48"},{"date":"2026.05.06","stock":"-0.49","trade":"-0.25","ind":"1.17"},{"date":"2026.04.30","stock":"-1.31","trade":"-0.48","ind":"0.11"},{"date":"2026.04.29","stock":"0.63","trade":"-0.20","ind":"0.71"},{"date":"2026.04.28","stock":"-0.83","trade":"-0.90","ind":"-0.19"},{"date":"2026.04.27","stock":"-2.69","trade":"-0.12","ind":"0.16"},{"date":"2026.04.24","stock":"-0.13","trade":"-1.02","ind":"-0.33"},{"date":"2026.04.23","stock":"-0.60","trade":"-2.31","ind":"-0.32"},{"date":"2026.04.22","stock":"-0.53","trade":"1.01","ind":"0.52"},{"date":"2026.04.21","stock":"0.07","trade":"-1.07","ind":"0.07"},{"date":"2026.04.20","stock":"-0.79","trade":"-0.70","ind":"0.76"},{"date":"2026.04.17","stock":"-1.49","trade":"-1.25","ind":"-0.10"},{"date":"2026.04.16","stock":"2.87","trade":"0.56","ind":"0.70"},{"date":"2026.04.15","stock":"1.56","trade":"1.39","ind":"0.01"},{"date":"2026.04.14","stock":"-0.20","trade":"1.04","ind":"0.95"},{"date":"2026.04.13","stock":"-0.81","trade":"0.23","ind":"0.06"},{"date":"2026.04.10","stock":"0.61","trade":"1.34","ind":"0.51"},{"date":"2026.04.09","stock":"-1.53","trade":"-1.48","ind":"-0.72"},{"date":"2026.04.08","stock":"1.90","trade":"1.96","ind":"2.70"},{"date":"2026.04.07","stock":"-0.47","trade":"0.21","ind":"0.26"},{"date":"2026.04.03","stock":"-2.75","trade":"-2.48","ind":"-1.00"}]
天坛生物,上证指数,生物制品指数
压力支撑
该股压力位为14.11元，支撑位为14.01元。
[{"text":"\u538b\u529b\u4f4d","value":"14.11","date":1778083200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"14.01","date":1778083200,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：1.9资金面打败了4%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：05月08日 08:07
| 机构今日流向(万元) | -1077.21 | 机构5日流向(万元) | -5141.99 |
| 机构10日流向(万元) | -11921.25 | 机构20日流向(万元) | -17278.17 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量减少3350.53万股，其中基金净减仓142家，主力净减仓26家，请投资者中长期谨慎为宜。
截止2025-12-31，共300家主力机构（基金296家，一般法人4家），持仓量总计116234.03万股，占流通A股58.78%
其中，基金持仓与2025-06-30相比：
增仓：37家 ，增持 385.11万股
减仓：179家 ，减持 3081.15万股
新出现在主力名单中：56家 ，持有433.98万股
从主力名单中消失：82家 ，原持有1904.18万股
其中，基金持仓与2025-06-30相比：
增仓：37家 ，增持 385.11万股
减仓：179家 ，减持 3081.15万股
新出现在主力名单中：56家 ，持有433.98万股
从主力名单中消失：82家 ，原持有1904.18万股
消息面诊股
诊断结果：6.2消息面打败了78%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 创新药+CXO+医疗器械+ 医疗服务+原料药：最强
2026-05-07 - 券商观点|医药2025年报及2026一季报总结：创
2026-05-07 - 天坛生物：5月6日获融资买入1410.12万元
2026-05-07 - 血液制品行业市场化升级：改变、加码、相信
2026-05-06 - 生物医药行业：创新提速、战略升级，整体企稳、结构分
2026-05-06 - 天坛生物一季度营业收入11.42亿元，同比下降13
2026-05-03 - 天坛生物：4月30日获融资买入1375.97万元
2026-05-01 - 诚通证券：给予天坛生物增持评级
2026-04-30 - 天坛生物：4月29日获融资买入873.25万元
2026-04-30 - 股东追踪|吴永强等新进天坛生物前十大流通股东
2026-04-29
消息列表
| 利好 | 分红转增 | 10派0.50元(含税) | 2026-03-28 |
| 一般消息 | 募资投向 | 2026-03-28 | |
| 一般消息 | 资产重组 | 公司股权转让 | 2026-03-07 |
| 一般消息 | 重大事项 | 关联交易 | 2026-01-17 |
| 一般消息 | 高管变动 | 工作调整 | 2026-01-16 |
| 一般消息 | 股东大会 | 临时股东大会 | 2026-01-01 |
| 一般消息 | 重大事项 | 关联交易 | 2026-01-01 |
| 一般消息 | 高管变动 | 工作调整 | 2025-12-31 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-12-31 |
| 一般消息 | 高管变动 | 工作调动 | 2025-09-28 |
| 利好 | 分红转增 | 10派1.50元(含税) | 2025-08-22 |
| 一般消息 | 重大事项 | 关联交易 | 2025-08-21 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 一般消息 | 重大事项 | 关联交易 | 2025-05-28 |
| 一般消息 | 高管变动 | 撤销监事会 | 2025-05-27 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 4条 | 0条 | 4条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：5.1行业面打败了67%的股票
生物制品行业最新资金流向
近10日来该行业走势不明显，明显跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，明显跑输大盘。
[{"date":"2026.05.07","price":"0.48","value":"0.68"},{"date":"2026.05.06","price":"1.17","value":"-0.25"},{"date":"2026.04.30","price":"0.11","value":"-0.48"},{"date":"2026.04.29","price":"0.71","value":"-0.20"},{"date":"2026.04.28","price":"-0.19","value":"-0.90"},{"date":"2026.04.27","price":"0.16","value":"-0.12"},{"date":"2026.04.24","price":"-0.33","value":"-1.02"},{"date":"2026.04.23","price":"-0.32","value":"-2.31"},{"date":"2026.04.22","price":"0.52","value":"1.01"},{"date":"2026.04.21","price":"0.07","value":"-1.07"},{"date":"2026.04.20","price":"0.76","value":"-0.70"},{"date":"2026.04.17","price":"-0.10","value":"-1.25"},{"date":"2026.04.16","price":"0.70","value":"0.56"},{"date":"2026.04.15","price":"0.01","value":"1.39"},{"date":"2026.04.14","price":"0.95","value":"1.04"},{"date":"2026.04.13","price":"0.06","value":"0.23"},{"date":"2026.04.10","price":"0.51","value":"1.34"},{"date":"2026.04.09","price":"-0.72","value":"-1.48"},{"date":"2026.04.08","price":"2.70","value":"1.96"},{"date":"2026.04.07","price":"0.26","value":"0.21"},{"date":"2026.04.03","price":"-1.00","value":"-2.48"}]
上证指数,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 赛伦生物 | 29.31% | 2.65% | 5.0分 |
| 2 | 昊帆生物 | 21.10% | -1.77% | 6.1分 |
| 3 | 近岸蛋白 | 19.30% | 3.30% | 4.7分 |
| 4 | *ST双成 | 18.75% | 3.75% | 6.5分 |
| 5 | 欧林生物 | 18.32% | 21.53% | 6.1分 |
| 6 | 万泽股份 | 15.39% | 3.98% | 6.0分 |
| 8 | 金迪克 | 8.55% | 3.43% | 5.0分 |
| 10 | 辽宁成大 | 6.96% | 4.45% | 5.8分 |
| 12 | 优宁维 | 6.06% | 2.49% | 6.2分 |
| 14 | 东宝生物 | 4.55% | 0.18% | 5.6分 |
| 16 | 诺唯赞 | 4.29% | 3.70% | 5.4分 |
| 18 | 康泰生物 | 3.33% | 1.49% | 4.8分 |
| 20 | 神州细胞 | 2.88% | 3.35% | 4.6分 |
| 22 | 智飞生物 | 0.33% | 3.01% | 5.3分 |
| 24 | 西藏药业 | -0.48% | 3.49% | 5.3分 |
| 26 | 华兰生物 | -1.30% | -0.28% | 4.9分 |
| 28 | 我武生物 | -1.76% | -4.35% | 4.7分 |
| 30 | 上海莱士 | -3.64% | 1.65% | 5.5分 |
| 32 | 赛升药业 | -4.43% | -6.42% | 4.1分 |
| 34 | 博晖创新 | -4.83% | -0.72% | 5.1分 |
| 36 | 艾迪药业 | -5.26% | -1.13% | 4.9分 |
| 38 | 博雅生物 | -6.61% | -3.18% | 4.6分 |
| 40 | 康辰药业 | -7.02% | -1.93% | 5.1分 |
| 42 | 诺诚健华 | -8.03% | -3.19% | 5.2分 |
| 44 | 派林生物 | -8.46% | -4.26% | 4.8分 |
| 46 | 安科生物 | -10.03% | -1.01% | 4.8分 |
| 48 | 荣昌生物 | -12.81% | -3.74% | 5.0分 |
| 50 | 康弘药业 | -14.14% | -2.81% | 4.9分 |
| 52 | 科兴制药 | -19.94% | -11.26% | 4.3分 |
| 54 | - | -46.10% | -35.49% | 分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2026-03-31 ]公司经营
盈利能力：较强，高于行业平均，两项指标的行业排名分别为 22/70 ， 43/70。
[{"date":"2026-03-31","value":"1.07","vol":"-2.96"},{"date":"2025-12-31","value":"9.54","vol":"-8.40"},{"date":"2025-09-30","value":"7.24","vol":"-10.09"},{"date":"2025-06-30","value":"5.57","vol":"-0.67"},{"date":"2025-03-31","value":"2.17","vol":"0.44"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
1.07 | 9.54 | 7.24 | 5.57 | 2.17 |
| 行业(%) | -2.96 | -8.40 | -10.09 | -0.67 | 0.44 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"34.59","vol":"61.64"},{"date":"2025-12-31","value":"43.85","vol":"66.98"},{"date":"2025-09-30","value":"43.81","vol":"67.71"},{"date":"2025-06-30","value":"45.40","vol":"67.98"},{"date":"2025-03-31","value":"45.87","vol":"69.02"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
34.59 | 43.85 | 43.81 | 45.40 | 45.87 |
| 行业(%) | 61.64 | 66.98 | 67.71 | 67.98 | 69.02 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 42/70 ， 39/70。
[{"date":"2026-03-31","value":"-13.36","vol":"16.15"},{"date":"2025-12-31","value":"2.26","vol":"35.93"},{"date":"2025-09-30","value":"9.62","vol":"45.81"},{"date":"2025-06-30","value":"9.47","vol":"7037.48"},{"date":"2025-03-31","value":"7.84","vol":"6245.21"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-13.36 | 2.26 | 9.62 | 9.47 | 7.84 |
| 行业(%) | 16.15 | 35.93 | 45.81 | 7037.48 | 6245.21 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"-48.45","vol":"74.78"},{"date":"2025-12-31","value":"-29.59","vol":"34.78"},{"date":"2025-09-30","value":"-22.16","vol":"45.67"},{"date":"2025-06-30","value":"-12.88","vol":"5.32"},{"date":"2025-03-31","value":"-22.90","vol":"-8.96"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-48.45 | -29.59 | -22.16 | -12.88 | -22.90 |
| 行业(%) | 74.78 | 34.78 | 45.67 | 5.32 | -8.96 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，两项指标的行业排名分别为 20/70 ， 29/70。
[{"date":"2026-03-31","value":"0.07","vol":"0.06"},{"date":"2025-12-31","value":"0.38","vol":"0.30"},{"date":"2025-09-30","value":"0.28","vol":"0.21"},{"date":"2025-06-30","value":"0.19","vol":"0.14"},{"date":"2025-03-31","value":"0.08","vol":"0.06"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.07 | 0.38 | 0.28 | 0.19 | 0.08 |
| 行业(次) | 0.06 | 0.30 | 0.21 | 0.14 | 0.06 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.18","vol":"0.29"},{"date":"2025-12-31","value":"0.88","vol":"1.30"},{"date":"2025-09-30","value":"0.63","vol":"0.90"},{"date":"2025-06-30","value":"0.44","vol":"0.56"},{"date":"2025-03-31","value":"0.18","vol":"0.26"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.18 | 0.88 | 0.63 | 0.44 | 0.18 |
| 行业(次) | 0.29 | 1.30 | 0.90 | 0.56 | 0.26 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-03-31","value":"-1.36","vol":"-71.66"},{"date":"2025-12-31","value":"13.03","vol":"12.85"},{"date":"2025-09-30","value":"23.53","vol":"0.21"},{"date":"2025-06-30","value":"5.56","vol":"-1404.66"},{"date":"2025-03-31","value":"-22.89","vol":"-47.97"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -1.36 | 13.03 | 23.53 | 5.56 | -22.89 |
| 行业 | -71.66 | 12.85 | 0.21 | -1404.66 | -47.97 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"1.32","vol":"1.77"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.43","vol":"1.58"},{"date":"2025-03-31","value":"","vol":"0.00"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.32 | - | 1.43 | - |
| 行业 | 0.00 | 1.77 | 0.00 | 1.58 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：尚可，接近行业平均，两项指标的行业排名分别为 42/70 ， 36/70。
[{"date":"2026-03-31","value":"8.82","vol":"6.75"},{"date":"2025-12-31","value":"8.00","vol":"5.88"},{"date":"2025-09-30","value":"6.01","vol":"6.07"},{"date":"2025-06-30","value":"6.39","vol":"6.70"},{"date":"2025-03-31","value":"7.19","vol":"7.82"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
8.82 | 8.00 | 6.01 | 6.39 | 7.19 |
| 行业 | 6.75 | 5.88 | 6.07 | 6.70 | 7.82 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"4.40","vol":"5.22"},{"date":"2025-12-31","value":"4.07","vol":"4.49"},{"date":"2025-09-30","value":"3.06","vol":"4.89"},{"date":"2025-06-30","value":"3.33","vol":"5.34"},{"date":"2025-03-31","value":"3.57","vol":"6.40"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
4.40 | 4.07 | 3.06 | 3.33 | 3.57 |
| 行业 | 5.22 | 4.49 | 4.89 | 5.34 | 6.40 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，两项指标的行业排名分别为 41/70 ， 40/70。
[{"date":"2026-03-31","value":"7.07","vol":"27.44"},{"date":"2025-12-31","value":"7.64","vol":"27.58"},{"date":"2025-09-30","value":"9.69","vol":"28.02"},{"date":"2025-06-30","value":"9.27","vol":"26.70"},{"date":"2025-03-31","value":"8.41","vol":"26.06"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
7.07 | 7.64 | 9.69 | 9.27 | 8.41 |
| 行业(%) | 27.44 | 27.58 | 28.02 | 26.70 | 26.06 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.10","vol":"1.46"},{"date":"2025-12-31","value":"0.11","vol":"1.28"},{"date":"2025-09-30","value":"0.14","vol":"0.58"},{"date":"2025-06-30","value":"0.13","vol":"1.13"},{"date":"2025-03-31","value":"0.12","vol":"0.79"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.10 | 0.11 | 0.14 | 0.13 | 0.12 |
| 行业(%) | 1.46 | 1.28 | 0.58 | 1.13 | 0.79 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 诚通证券 | 2026-04-29 | 增持 | |
| 兴业证券 | 2026-04-24 | 增持 | |
| 国投证券 | 2026-04-02 | 买入 | |
| 国泰海通证券 | 2026-04-01 | 买入 | |
| 中国银河 | 2026-03-28 | 买入 | |
| 光大证券 | 2026-03-23 | 买入 |
机构预测
机构预测该股2026年每股收益与前一年相同，长期投资价值一般。
[{"date":"2022","yellowRectValue":"8.81","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"11.10","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"15.49","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"10.91","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"12.45","blueLineValue":"0.63","type":"YC"}]